These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 7617551)

  • 21. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
    De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
    Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors.
    Jamwal S; Mittal A; Kumar P; Alhayani DM; Al-Aboudi A
    Curr Pharm Des; 2019; 25(26):2892-2905. PubMed ID: 31333104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release.
    Koolpe M; Pearson D; Benton HP
    Arthritis Rheum; 1999 Feb; 42(2):258-67. PubMed ID: 10025919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of P1 (adenosine) purinoceptors.
    Jarvis MF
    Curr Protoc Pharmacol; 2013 Oct; 62():1.9.1-1.9.16. PubMed ID: 24510716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the presence of both P1 and P2 purinoceptors in the rat myometrium.
    Gillman TA; Pennefather JN
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):592-9. PubMed ID: 9673434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purines as neurotransmitters and neuromodulators in blood vessels.
    Ralevic V
    Curr Vasc Pharmacol; 2009 Jan; 7(1):3-14. PubMed ID: 19149635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release.
    Rayment SJ; Ralevic V; Barrett DA; Cordell R; Alexander SP
    FASEB J; 2007 Feb; 21(2):577-85. PubMed ID: 17167068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular nucleotide and nucleoside signaling in vascular and blood disease.
    Idzko M; Ferrari D; Riegel AK; Eltzschig HK
    Blood; 2014 Aug; 124(7):1029-37. PubMed ID: 25001468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purinergic and pyrimidinergic receptors as potential drug targets.
    Williams M; Jarvis MF
    Biochem Pharmacol; 2000 May; 59(10):1173-85. PubMed ID: 10736418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
    Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
    Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors.
    Chen Y; Shukla A; Namiki S; Insel PA; Junger WG
    J Leukoc Biol; 2004 Jul; 76(1):245-53. PubMed ID: 15107462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and function of adenosine receptor heteromers.
    Franco R; Cordomí A; Llinas Del Torrent C; Lillo A; Serrano-Marín J; Navarro G; Pardo L
    Cell Mol Life Sci; 2021 Apr; 78(8):3957-3968. PubMed ID: 33580270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [125I]4-aminobenzyl-5'-N-methylcarboxamidoadenosine (125I)AB-MECA) labels multiple adenosine receptor subtypes in rat brain.
    Shearman LP; Weaver DR
    Brain Res; 1997 Jan; 745(1-2):10-20. PubMed ID: 9037389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P2 purinoceptors contribute to ATP-induced inhibition of L-type Ca2+ current in rabbit atrial myocytes.
    Yamamoto T; Habuchi Y; Nishio M; Morikawa J; Tanaka H
    Cardiovasc Res; 1999 Jan; 41(1):166-74. PubMed ID: 10325964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purines and neutrophil leukocytes.
    Fredholm BB
    Gen Pharmacol; 1997 Mar; 28(3):345-50. PubMed ID: 9068971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine A2A receptor-mediated facilitation of noradrenaline release involves protein kinase C activation and attenuation of presynaptic inhibitory receptor-mediated effects in the rat vas deferens.
    Queiroz G; Talaia C; Gonçalves J
    J Neurochem; 2003 May; 85(3):740-8. PubMed ID: 12694400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine.
    Fredholm BB
    Pharmacol Toxicol; 1995 Feb; 76(2):93-101. PubMed ID: 7746802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.